Whole genome sequencing of seven cases of prostate cancer revealed that, in addition to mutational events occurring in the PTEN gene due to breakpoints, rearrangements disrupting the MAGI2 gene, encoding for a PTEN-interacting protein, have been observed [53]. This evidence concerns the gene PTEN and prostate carcinoma.